Press Releases :: CohBar, Inc. (CWBR)

CohBar, Inc. and Morphogenesis, Inc. Enter into Definitive Merger Agreement to Advance an Innovative Late-stage Clinical Immuno-oncology Pipeline of Therapies to Overcome Resistance to Cancer Immunotherapy

The companies hosted a joint webcast on May 23, 2023, to discuss the transaction.

Morphogenesis Website

Access Webcast Replay

Jul 06, 2020 9:00am EDT

CohBar to Present at Sachs Novel Coronavirus Investment Forum

Jun 30, 2020 9:00am EDT

CohBar Added to Russell 2000® Index and Raises $4.4M in ATM Offering

Jun 17, 2020 9:00am EDT

CohBar Founder Dr. Nir Barzilai’s New Book “AGE LATER” Reveals that Aging Can Be Seen as a Preventable Disease

Jun 02, 2020 9:00am EDT

CohBar to Hold 2020 Annual Shareholder Meeting and Investor Update June 16, 2020

May 27, 2020 9:00am EDT

CohBar’s CEO to Participate on the New Breakthroughs in Aging Biology Panel at the BIO 2020 Digital Conference

May 14, 2020 4:02pm EDT

CohBar Reports First Quarter 2020 Financial Results and Provides Business Update

May 13, 2020 9:00am EDT

CohBar’s Chief Operating Officer Jon Stern Plans to Step Down from Management Role

May 05, 2020 9:00am EDT

CohBar To Target COVID-19 Associated Acute Respiratory Distress Syndrome (ARDS) with its Apelin Receptor Agonist Peptides

May 01, 2020 11:00am EDT

CohBar’s Abstract for the American Thoracic Society 2020 International Conference Published in the American Journal of Respiratory and Critical Care Medicine

Apr 30, 2020 9:00am EDT

CohBar to Announce 2020 First Quarter Financial Results and Provide Business Update on May 14, 2020